The Azerbaijani veterinary vaccine market excluding foot and mouth disease has shown a consistent decline in value per capita from 2013 to 2023, reducing from $2.56 to $1.73. This represents a continuous trend of decline with an average decrease of approximately 3.56% per year over the last 5 years. The year-on-year percentage variations for the last two years were approximately -2.74% from 2021 to 2022 and -2.81% from 2022 to 2023, underscoring a persistent downtrend.
Future trends to watch for include potential healthcare policy changes or advancements in veterinary medicine within Azerbaijan that could impact vaccine utilization. Additionally, international trade agreements or economic shifts might influence supply chains and pricing, affecting future market dynamics.
